Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre prospective, observational cohort study

(1) Montpellier University Hospital,Montpellier,France

(2) Saint-Louis Hospital International Program to Develop New Indexes in Cr,Lille,France

(3) Gastroenterology & Nutrition Department,Paris,France

(4) Hopital Saint Eloi Hepatologie Gastroenterologie,Montpellier Cedex,France

(5) Besançon University Hospital Gastroenterology,Courbevoie,France

(6) Beujon Hospital,Clichy,France

(7) Lyon University Hospital,Lyon,France

(8) Tours University Hospital,Tours,France

(9) Hopital Nord,Marseille,France

(10) Nancy University Hospital Inserm U 954,Vandoeuvre les Nancy,France

(11) Hopital de lAchet, Dept. de Nutrition Oncologie,Nice Cedex 3,France

(12) CHRU de Caen HGE,Caen Cedex,France

(13) Hopital Cochin Gastroentérologie,Paris Cedex 14,France

(14) Valenciennes General Hospital,Valenciennes,France

(15) Hopital Hotel Dieu et HME,Nantes Cedex,France

(16) Lille University Hospital,Lille,France

(17) Centre Hospitalier Universitaire de Toulouse, Hopital Rangueil,Toulouse,France

(18) CHU Estaing Clermont-Ferrand,Clermont-Ferrand,France

(19) University of St. Etienne Dept. de Gastroenterologie,Saint Etienne,France

(20) Hospital Beaujon,Clichy,France

(21) Saint-Louis Hospital,Paris,France

(22) CHU Beaujon Dept. of IBD and Nutrition,Clichy,France



This item was part of the Randomised controlled trials in IBD II session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019